Synthon B.V., Synthon Hispania S.L.
PolandAll drugs from this manufacturer
-
The medicine is intended for adult patients with advanced non-small cell lung cancer (provided that specific EGFR mutations are present) or in the case of metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC: L01EB02
-
The medicinal product is used in adult patients with advanced non-small cell lung cancer and in patients with metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC: L01EB02
-
It is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 2.5 mg ATC: L01EG02
-
It is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 5 mg ATC: L01EG02
-
This is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 10 mg ATC: L01EG02
-
The medicinal product is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women, in combination with exemestane), advanced neuroendocrine tumours (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 2.5 mg ATC: L01XE10
-
The medicine is used in adult patients with advanced breast cancer (in postmenopausal women, in combination with exemestane), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 5 mg ATC: L01XE10
-
The medicine is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 10 mg ATC: L01XE10
-
This is an anticancer medicine used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 2.5 mg ATC: L01XE10
-
This is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.
Dosage form: tablets
Active substance Dosage everolimus 5 mg ATC: L01XE10
-
This is an anticancer medicine used in adults for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced kidney cancer.
Dosage form: tablets
Active substance Dosage everolimus 10 mg ATC: L01XE10
-
The medicine is used to remove excess iron from the body. It is intended for the treatment of chronic iron overload in patients with severe beta thalassemia, in patients with other types of anemia, and in individuals with transfusion-independent thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 90 mg ATC: V03AC03
-
Exferana is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who experience chronic iron overload due to frequent blood transfusions, and for patients with other types of anemia or thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 180 mg ATC: V03AC03
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who have chronic iron overload due to frequent blood transfusions, as well as for patients with other types of anemia or thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 360 mg ATC: V03AC03
-
Fenoxa is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly in patients for whom treatment is not effective or in whom the disease is progressing rapidly and severely.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom other treatments have not worked or in whom the disease is progressing rapidly and severely.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
-
The medicine is intended for adult patients with relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom previous treatment has not been effective or in whom the disease is progressing rapidly and severely. It helps to reduce the number of relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS). It helps to reduce the number of disease relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals for whom other treatments have not worked or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
The medicine is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps improve urine flow, makes urination easier, and reduces the sudden urge to use the toilet.
Dosage form: tablets, prolonged release
Active substance Dosage tamsulosin hydrochloride 0.4 mg ATC: G04CA02
-
The medicine is used in adult patients for the treatment of non-small cell lung cancer.
Dosage form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01EB01
-
It is used in adult patients for the treatment of non-small cell lung cancer.
Dosage form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01XE02
-
The medicine is used for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss, increase bone mass, and reduce the risk of vertebral fractures.
Dosage form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg ATC: M05BA06
-
The medicine is used in adults in the case of breast cancer that has spread to the bones. It helps to prevent fractures and bone complications requiring surgery or radiation by inhibiting the loss of calcium from the bones.
Dosage form: tablets, film-coated
Active substance Dosage ibandronic acid monohydrate sodium 56.25 mg ATC: M05BA06
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of advanced or progressive thyroid cancer, liver cancer, endometrial cancer, and kidney cancer (depending on the specific case and concomitant medications used).
Dosage form: capsules, hard
Active substance Dosage lenvatinib 4 mg ATC: L01EX08
-
The medicine is used in adults for the treatment of, among others, progressive or advanced thyroid cancer, liver cancer, advanced uterine cancer, and advanced kidney cancer (it may be used alone or in combination with other anticancer medicines).
Dosage form: capsules, hard
Active substance Dosage lenvatinib 10 mg ATC: L01EX08
-
It is an anti-allergic medication used to treat the symptoms of allergic rhinitis (including chronic) and urticaria (hives).
Dosage form: tablets, film-coated
Active substance Dosage levocetirizine dihydrochloride 5 mg ATC: R06AE09
-
The medicine is used to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia). It helps to facilitate urination and reduces bladder urgency.
Dosage form: capsules, hard modified release
Active substance Dosage tamsulosin hydrochloride 0.4 mg ATC: G04CA02
-
This medicine is intended for the treatment of adults with multiple myeloma. It is used in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC: L04AX06
-
The medicinal product is used in adults for the treatment of multiple myeloma. It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
This medicine is used in adults to treat multiple myeloma. It may be administered in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
This medicine is used in adults to treat multiple myeloma. It may be used alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC: L04AX06